Comparison of Efficacy and Safety of Vildagliptin and Linagliptin in Patients of Type 2 Diabetes Mellitus with Chronic Kidney Disease. Community Based Medical Journal, [S. l.], v. 14, n. 1, p. 96–100, 2025. DOI: 10.3329/cbmj.v14i1.79340. Disponível em: https://banglajol.info/index.php/CBMJ/article/view/79340. Acesso em: 3 jul. 2026.